https://www.statnews.com/2023/11/11/heart-attack-stroke-obesity-wegovy-novo-nordisk-select/
Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.
Create an account or login to join the discussion